ZhaoLHuHZhangL, et al. Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions. Medcomm (2020). 2024;5(4):e516.
2.
KoshinoASchechterMSenT, et al. Interleukin-6 and cardiovascular and kidney outcomes in patients with type 2 diabetes: new insights from CANVAS. Diabetes Care. 2022;45(11):2644-2652.
3.
ZografouIKouroupisDDimakopoulosGDoukelisPDoumasMKoufakisT. Correlation between presepsin levels and continuous glucose monitoring metrics in infection-free individuals with type 1 diabetes. J Diabetes Sci Technol. 2025;19(1):277-278.
4.
JinZZhangQLiuK, et al. The association between interleukin family and diabetes mellitus and its complications: an overview of systematic reviews and meta-analyses. Diabetes Res Clin Pract. 2024;210:111615.
5.
DotsonSFreemanRFailingHJAdlerGK. Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care. 2008;31(6):1222-1223.
6.
DevarajSVenugopalSKSinghUJialalI. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes. 2005;54(1):85-91.
